Luigi Mangione, the 26-year-old accused of killing UnitedHealthcare CEO Brian Thompson on a busy Manhattan sidewalk, has arrived in court for a status hearing, sparking public interest and debate about the case and its implications for the healthcare industry. The prosecution and defense are expected to give updates on the status of the case, and Judge Gregory Carro could set pretrial paperwork deadlines and might set a trial date. Mangione has pleaded not guilty to state charges but has yet to enter a plea on federal murder charges related to the killing of Thompson as the executive walked toward the hotel hosting UnitedHealthcare’s annual investor conference in Midtown Manhattan on December 4.

Although it’s unclear if the status hearing will include any major updates in Mangione’s case, it has attracted dozens of supporters and observers – a reflection of public fascination with the killing and Mangione himself. The suspect’s attorney, Karen Friedman Agnifilo, was greeted with applause and cheers when she arrived at the courthouse. Signs of sympathy and support for Mangione dotted the scene outside the courtroom, with posters of the CEOs of other major health care corporations appearing nearby the court, with the word “WANTED” emblazoned above a picture of each executive. The healthcare industry has been under scrutiny in recent years, with many Americans expressing frustration with the high costs and limited access to quality care.

A Manhattan grand jury has indicted Mangione with an 11-count indictment, which includes one count of murder in the first degree and two counts of murder in the second degree, along with other weapon and forgery charges. His Friday court hearing is scheduled to start at 2:15 p.m. ET. The first-degree murder charge alleges he killed the executive “in furtherance of an act of terrorism,” which is legally defined as an intent to intimidate or coerce the civilian population or a government unit. One of the second-degree counts also alleges Mangione committed murder “as a crime of terrorism.” He faces a sentence of life in prison without the possibility of parole if convicted, according to the Manhattan District Attorney.

The public was captivated by the weeklong manhunt for Thompson’s alleged killer, which ended when a customer and a worker at a Pennsylvania McDonald’s reported Mangione to the police. When Mangione was arrested in Pennsylvania, investigators allegedly found on him the fake ID used by the suspect, the gun they believe was used in the shooting, and a handwritten “claim of responsibility,” authorities have said. A charge of murder in the first degree is rare in New York because it requires special elements related to the crime to be charged. Under state law, murder in the first degree only applies to a narrow list of aggravating circumstances, including when the victim is a judge, a police officer or a first responder, or when the killing involves a murder-for-hire or an intent to commit terrorism.

Here are some key points about the case: * Mangione has pleaded not guilty to state charges but has yet to enter a plea on federal murder charges * A Manhattan grand jury has indicted Mangione with an 11-count indictment * The first-degree murder charge alleges he killed the executive “in furtherance of an act of terrorism” * Mangione faces a sentence of life in prison without the possibility of parole if convicted * The case has sparked public interest and debate about the healthcare industry and its implications for the case. Mangione has received widespread public support, from offers to help pay for his legal bills to an extended applause at the mention of his name in a comedy bit on “Saturday Night Live.” The killing of Thompson, a husband and father of two, unleashed what some observers describe as Americans’ pent-up anger and frustration with the nation’s health insurance industry.